Advancing Business, Technology and Innovation for Vaccines in East Asia
In the face of dynamic global health challenges, the imperative for ground breaking solutions has surged to unprecedented heights. The 6th Vaccine World East Asia Congress emerges as a pivotal rendezvous point, uniting brilliant minds to explore and deliberate on cutting-edge advancements in vaccine research and development (R&D), innovative manufacturing processes, and the transformative potential of state-of-the-art technologies.
Our agenda is poised to nurture collaboration, facilitate the exchange of insights, and showcase ground breaking case studies that illuminate the path ahead in vaccine development and manufacturing. From delving into the frontiers of immunology breakthroughs to dissecting the intricacies of precision manufacturing, the 6th Vaccine World East Asia Congress is committed to navigating the ever-evolving terrain of vaccine innovation.
Key themes in the discussions include the swift acceleration of research initiatives, the optimization of manufacturing capabilities, and the seamless integration of novel technologies poised to revolutionize vaccine development. With an extraordinary assembly of visionaries, innovators, and leaders propelling the forefront of vaccine research and development, delegates can eagerly anticipate engaging in thought-provoking discussions that traverse the latest trends, navigate challenges, and celebrate success stories shaping the future of vaccines not only in East Asia but on a global scale.
Industry leaders convene to discuss the challenges and opportunities in vaccine research, manufacturing, and supply chain management across East Asia, addressing topics such as technology innovation, regulatory hurdles, and regional collaboration.
Discusses innovative strategies and methodologies in vaccine clinical trials and research and development, including adaptive trial designs, novel adjuvants, and antigen discovery platforms to expedite vaccine development.
Discusses innovative approaches and technologies in designing next-generation vaccines, including novel delivery systems, antigen design, and immunomodulatory strategies to enhance efficacy and safety.
Presents case studies and success stories of vaccine research and manufacturing initiatives in East Asia, highlighting technological innovations, collaboration models, and market dynamics.
Focuses on the upstream and downstream processes involved in vaccine manufacturing, covering topics such as cell culture techniques, purification methods, and optimization strategies to enhance production yield and quality.
Focuses on the critical aspects of aseptic fill-finish operations and packaging in vaccine manufacturing, addressing technologies, equipment, and regulatory considerations to ensure product sterility and integrity.
Examines challenges and solutions in managing the vaccine supply chain, with a focus on temperature-sensitive products, discussing logistics strategies, cold chain management, and risk mitigation measures.
Explores the current state and future prospects of mRNA vaccines, including technological advancements, clinical applications, and potential breakthroughs in vaccine development and delivery.
Standard Price:
SGD 2,795
*THIS PRICING IS APPLICABLE TO:
Company Profiles: Local Biopharma, Asian Academic & Research Institutes.
Standard Price:
SGD 4,695
*THIS PRICING IS APPLICABLE TO:
Company Profile: Technology and Solutions Provider, International Biopharma, BIG Pharmas, CMO’s.
Standard Price:
SGD 2,795
*THIS PRICING IS APPLICABLE TO:
Company Profiles: Local Biopharma, Asian Academic & Research Institutes.
Standard Price:
SGD 4,695
*THIS PRICING IS APPLICABLE TO:
Company Profile: Technology and Solutions Provider, International Biopharma, BIG Pharmas, CMO’s.
IVI’s laboratory science division designs new vaccines, improves the formulation of existing vaccines, conducts preclinical studies, evaluates the safety and performance of promising vaccine candidates, develops technologies to support vaccine clinical testing in human, optimizes production processes in advance of industrial-level scale-up, and transfers vaccine technology to manufacturers. Technology transfer takes place on the condition that selected manufacturers produce high-quality vaccines at low cost in a country with a functional National Regulatory Authority accredited by WHO.
Our laboratories in Seoul are equipped with microbiological, immunological, and genomic containment as well as BSL-3, BSL-2, GCLP labs and animal facilities. Our teams specialize in molecular biology, microbial genetics, bioinformatics, and immunology.
IMAPAC is the go-to holistic producer of live events, biopharma data and digital marketing solutions for the global biopharmaceutical industry.
© 2024 Imapac. All rights reserved. Trade marks are owned by or licensed to imapac.
Advancing Business, Technology and Innovation for Vaccines in East Asia